Therapeutic Response of Metastatic Colorectal Cancer Harboring a KRAS Missense Mutation After Combination Chemotherapy With the EGFR Inhibitor Panitumumab.
published in: Journal of the National Comprehensive Cancer Network
date of publication: 2017-04-01
main subject: colorectal cancer, metastatic colon cancer
Cites articles 20
Date
Title
Article - wd:Q51061699